+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunofluorescence staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus using monoclonal antibody to reduced glycated lysine



Immunofluorescence staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus using monoclonal antibody to reduced glycated lysine



Journal Of Diabetes & Its Complications. 10(6): 314-319



This is the first report on immunofluorescence staining of renal biopsy samples in human diabetic nephropathy (DN) using monoclonal antibodies to reduced glycated lysine. In order to detect the localization of glycated lysine in the mesangial matrix and/or the glomerular basement membrane (GBM), we examined immunofluorescence staining using antibodies against reduced glycated lysine in the glomeruli of 16 patients with DN and ten age-matched patients with diffuse mesangial proliferative glomerulonephritis without IgA deposition (DPGN) as controls. In the early stage of DN, immunofluorescence microscopy revealed the presence of intense staining for reduced glycated lysine in the GBM as well as in part of the tubular basement membrane, but not in the mesangial area. In contrast, immunofluorescence microscopy revealed less staining for glycated lysine in the GBM in the advanced stage of DN, and no reaction with any part of the renal tissue in patients with DPGN. It was concluded that detection of reduced glycated lysine in GBM in the early stage of DN might be associated with the initial pathogenesis of this disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008818937

Download citation: RISBibTeXText

PMID: 8972382

DOI: 10.1016/1056-8727(95)00060-7


Related references

Immunohistochemical staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin dependent diabetes mellitus using monoclonal antibody to advanced glycation end products. Nephrology 1(3): 199-205, 1995

Detection of Amadori products of renal biopsy samples in patients with diabetic nephropathy using polyclonal antibody to hexitol-lysine. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 119A, Sept, 1998

Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy. Diabetes Research and Clinical Practice 12(3): 149-156, 1991

Immunofluorescence staining in unfixed or fixed renal biopsy specimens from patients with diabetic nephropathy. Acta Pathologica Japonica 35(5): 1135-1140, 1985

Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy. Diabetes Research 4(4): 159-162, 1987

The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia 42(5): 519-526, 1999

Protective effect of angiotensin coverting enzyme inhibitor on renal function in normotensive non-insulin dependent diabetes mellitus patients with early diabetic nephropathy and microalbuminuria. Zhonghua Nei Ke Za Zhi 35(8): 533-536, 1996

Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors. Terapevticheskii Arkhiv 72(6): 52-54, 2000

Evaluation of the staining findings of immunofluorescence in unfixed or fixed renal biopsy specimens from patients with IgA nephropathy and membranous nephropathy. Acta Pathologica Japonica 35(2): 315-321, 1985

Evaluation of the staining findings of immunofluorescence in unfixed or fixed renal biopsy specimens from patients with immunoglobulin a nephropathy and membranous nephropathy. Acta Pathologica Japonica 35(2): 315-322, 1985

Correlates of biopsy-studied nephropathy in young patients with insulin-dependent diabetes mellitus. Journal of Pediatrics 106(2): 196-201, 1985

The prevalence of diabetic nephropathy in adult patients with insulin dependent diabetes mellitus attending Parirenyatwa Diabetic Clinic, Harare. Central African Journal of Medicine 53(1-4): 1-6, 2010

Determinants of diabetic nephropathy in patients with less than 15 years of insulin-dependent diabetes mellitus. Journal of the American Society of Nephrology 4(3): 304, 1993

Chronotherapy with trental of patients with insulin-dependent diabetes mellitus and diabetic nephropathy. Cardiovascular Drugs & Therapy 11(SUPPL 2): 332, 1997

Bone loss in insulin dependent diabetes mellitus patients without diabetic nephropathy. Diabetologia 40(SUPPL 1): A579, 1997